Published in Surgery on February 01, 1982
Rupture of multiple splenic artery aneurysms: a common presentation of a rare disease with a review of literature. Saudi J Gastroenterol (2009) 1.11
Incidental splenic artery aneurysm. J R Soc Med (2002) 0.97
Splenic artery aneurysm associated with systemic lupus erythematosus: report of a case. Surg Today (1999) 0.96
Haematochezia from a Splenic Artery Pseudoaneurysm Communicating with Transverse Colon: A Case Report and Literature Review. Case Rep Vasc Med (2016) 0.87
Endovascular Treatment of a Ruptured Splenic Artery Aneurysm using Amplatzer(®) Vascular Plug. Int J Biomed Sci (2009) 0.85
Embolization of giant aneurysm and pseudoaneurysm of the splenic artery. Eur Radiol (2000) 0.76
The diagnosis and management of splenic artery aneurysms. J R Soc Med (1988) 0.75
Preservation of arterial flow to the liver: goal in treatment of extrahepatic and post-traumatic intrahepatic aneurysms of the hepatic artery. Ann Surg (1982) 0.75
Splenic artery aneurysm as an unusual cause of new onset ascites: a case report. Middle East J Dig Dis (2014) 0.75
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A (1993) 4.45
Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet (1994) 3.45
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol (1993) 3.36
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today (1994) 3.25
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14
Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01
Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol (1988) 2.95
Interleukin-10. Curr Opin Immunol (1992) 2.85
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70
Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol (1985) 2.70
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
A novel receptor involved in T-cell activation. Nature (1995) 2.56
Appendicitis near its centenary. Ann Surg (1984) 2.56
Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood (1990) 2.48
B cell growth-promoting activity of recombinant human interleukin 4. J Immunol (1987) 2.31
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med (1991) 2.27
Operative and nonoperative management of esophageal perforations. Ann Surg (1981) 2.24
Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13
Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med (1990) 2.09
Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol (1991) 2.07
[Interval appendectomy as indicated rather than as routine therapy: fewer operations and shorter hospital stays]. Ned Tijdschr Geneeskd (2007) 1.98
Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity (1997) 1.97
Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood (1982) 1.83
Narrower margins for clinical stage I malignant melanoma. N Engl J Med (1982) 1.82
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81
Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med (1996) 1.80
Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma (1983) 1.79
Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol (1990) 1.79
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet (1989) 1.70
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol (1988) 1.67
The role of monocytes in human lymphocyte activation by mitogens. J Immunol (1979) 1.67
Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer (1975) 1.65
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol (1993) 1.62
Tube gastrostomy. Techniques and complications. Ann Surg (1985) 1.54
Transforming growth factor-beta directs IgA switching in human B cells. J Immunol (1992) 1.53
IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol (1992) 1.51
Fascia closure after midline laparotomy: results of a randomized trial. Br J Surg (1987) 1.44
Long-term utility of replanted arms. Ann Surg (1972) 1.42
Biliary stricture dilatation: multicenter review of clinical management in 73 patients. Radiology (1986) 1.41
The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med (1993) 1.41
Interleukin-4 mediates CD8 induction on human CD4+ T-cell clones. Nature (1988) 1.41
Clinical correlates of resectability and survival in gastric carcinoma. Ann Surg (1978) 1.40
Compensatory growth of the kidney. N Engl J Med (1969) 1.40
Management of bleeding esophageal varices. West J Med (1982) 1.40
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol (2004) 1.39
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol (1988) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Management of carcinoid tumors of the gastrointestinal tract. Surg Gynecol Obstet (1977) 1.38
Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med (1997) 1.37
Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol (1997) 1.37
Adenocarcinoma and lymphoma of the small intestine. Distribution and etiologic associations. Ann Surg (1983) 1.36
Humoral regulation of renal mass. Surgery (1972) 1.36
Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes. J Immunol (1986) 1.35
Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J Immunol (1999) 1.35
Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest (1990) 1.35
Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science (1986) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Promotion of azoxymethane-induced colonic neoplasia by resection of the proximal small bowel. Cancer Res (1978) 1.31
Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol (1991) 1.30
The perforated appendix. N Engl J Med (1986) 1.29
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol (1984) 1.29
Natural killer cell clones can efficiently process and present protein antigens. J Immunol (1991) 1.28
Humoral stimulation of cell proliferation in small bowel after transection and resection in rats. Gastroenterology (1978) 1.28
Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. Mol Immunol (1989) 1.27
Accretion and turnover of RNA in the renoprival kidney. Am J Physiol (1968) 1.27
Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23). J Cell Biochem (1989) 1.26
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol (1991) 1.26
Contrasting effects of subtotal enteric bypass, enterectomy, and colectomy on azoxymethane-induced intestinal carcinogenesis. Cancer Res (1980) 1.26
Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol (1991) 1.24
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int Immunol (1992) 1.23
Outcome of cholecystostomy. Surg Gynecol Obstet (1972) 1.22
Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci U S A (1980) 1.22
Elective and emergency hepatic resection. Determinants of operative mortality and morbidity. Ann Surg (1991) 1.21
Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol (1989) 1.21
Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol (1992) 1.18
IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J Immunol (1994) 1.17
Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood. J Immunol (1991) 1.17
Colostomy closure promotes cell proliferation and dimethylhydrazine-induced carcinogenesis in rat distal colon. Gastroenterology (1981) 1.15
Predictors of surgical mortality in patients with cirrhosis and nonvariceal gastroduodenal bleeding. Surg Gynecol Obstet (1974) 1.15
Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur J Immunol (1996) 1.13
Modification of nucleic acid synthesis in regenerating liver by azathioprine. Surgery (1970) 1.13
Onset of cell proliferation in the shortened gut. Rapid hyperplasia after jejunal resection. Gastroenterology (1977) 1.12
IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes. J Immunol (1990) 1.12
IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol (1993) 1.11
IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. Int Immunol (1994) 1.09
Feasibility of obtaining Raman spectra from nucleic acid constituents. Biochim Biophys Acta (1966) 1.09
Membrane glycoprotein p150,95 of human cytotoxic T cell clone is involved in conjugate formation with target cells. J Immunol (1987) 1.09